Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-07-20 | Reverse | 1:10 |
| 2026-03-27 | Reverse | 1:25 |
| 2025-10-13 | Reverse | 1:8 |
| 2025-05-20 | Reverse | 1:15 |
| 2025-01-27 | Reverse | 1:100 |
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

CDT Equity Inc. is a clinical-stage biopharmaceutical company developing unprioritized assets like a glucokinase activator for autoimmune diseases and a male infertility treatment, aiming to advance trials and license assets for further development.
| Icon | PRODUCT | Q2-2025 | Q3-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Automation Solutions | $365.97M | $381.31M ▲ | $387.01M ▲ | $436.77M ▲ |
![]() | Smart Buildings Solutions | — | — | $154.08M | $156.36M ▲ |
| Map | REGION | Q2-2025 | Q3-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Americas | $448.61M | $468.39M ▲ | $472.73M ▲ | $490.65M ▲ |
![]() | EMEA | $135.91M | $142.71M ▲ | $142.95M ▲ | $154.81M ▲ |
![]() | Asia Pacific | $87.47M | $87.13M ▼ | $80.69M ▼ | $104.69M ▲ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
COCH | $0.69 | COMPARE |
HEPA | $0.10 | COMPARE |
ZVSA | $0.10 | COMPARE |
ENVB | $1.37 | COMPARE |
CCM | $4.76 | COMPARE |
XAGE | $0.22 | COMPARE |
PTPI | $0.00 | COMPARE |
NIVF | $0.42 | COMPARE |